Aripiprazole CAS 129722-12-9 Mama >99.0% (HPLC) API
Faumea Faufautua Tuuina atu Intermediates o Aripiprazole ma maualuga mama
Aripiprazole API CAS 129722-12-9
1-(2,3-Dichlorophenyl)piperazine Hydrochloride CAS 119532-26-2
7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone CAS 22246-18-0
7-(4-Bromobutoxy)-3,4-Dihydro-2(1H)-Quinolinone CAS 129722-34-5
Igoa Vailaau | Aripiprazole |
Synonyms | 7-[4-[4-(2,3-Dichlorophenyl)-1-Piperazinyl]butoxy]-3,4-Dihydro-2(1H)-Quinolinone |
Numera CAS | 129722-12-9 |
CAT Numera | RF-PI2270 |
Tulaga Fa'asoa | I Fa'atauga, Oloa Fua e O'o i Tone |
Fuafua mole | C23H27Cl2N3O2 |
Molecular Weight | 448.39 |
Solubility | E le mafai ona solu i le Vai;E le mafai ona fa'afefe i le Methanol |
Fa'ailoga | Ruifu Chemical |
Aitema | Fa'amatalaga |
Fa'aaliga | Pa'epa'e po'o le Toeitiiti Pa'epa'e Pa'u tioata |
Fa'ailoaga | Saunia e IR;Saunia e HPLC |
Solubility | Solu i le Acetic Acid, Laititi Solu i Ethanol |
Lisi Lisi | 136.0~140.0 ℃ |
Ma'imau ile Fa'amago | <0.50% |
Toega i luga o le mumu | <0.10% |
Metala mamafa | ≤20ppm |
Solvents totoe | |
Ethanol | ≤1000ppm |
DMF | ≤200ppm |
Mea Fa'atatau | |
So'o se Fa'aleaga Ta'itasi | <0.20% |
Aofa'i Fa'aleaga | <1.00% |
Mama / Suʻesuʻega Metotia | >99.0% (HPLC) |
Su'ega | 98.0%~102.0% (i luga o le Anhydrous Basis) |
Micro Tapulaa | |
Aofa'i Aerobic Microbial Faitau | ≤1000 cfu/g |
Faafefete ma Maliu Tuufaatasi | ≤100 cfu/g |
E·Coli | Toesea |
Fa'atonuga fa'ama'i | Toesea |
Tulaga Su'ega | Pisinisi Tulaga |
Fa'aoga | API;Antipsychotic |
afifi: Fagu, 5kg / Aluminium apa, 25kg / Cardboard Drum, pe tusa ai ma manaoga o tagata faatau
Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama ma le susu
Aripiprazole (CAS: 129722-12-9) o se ituaiga fou o mea e maua mai i le quinoline e sili ona lipid soluble, o lona aafiaga faʻafomaʻi uiga e le gata i le postsynaptic dopamine D2 receptor antagonist, ae o le presynaptic dopamine D2 receptor agonist, e mafai foi. fa'aosofia le D1, D3, D4 fa'afofoga.Aripiprazole o se augatupulaga lona lua atypical antipsychotic ma anti-depressant ma vaega agonist gaoioiga i le dopamine D2 ma le serotonin 5-HT1A tali atu ma gaoioiga tetee i le serotonin 5-HT2A tali atu.O tau o le Ki o 0.34 nM, 0.8 nM, 1.7 nM, ma le 3.4 nM, i le faasologa, mo le dopamine D2 ma le D3, serotonin 5-HT1A ma 5-HT2A faʻafeiloaʻi.Aripiprazole e faʻaaogaina mo togafitiga o le schizophrenia ma faʻafitauli o le mafaufau.Bristol-Myers Squibb ma Otsuka Pharmaceutical Company na faasilasila mai ua faamaonia e le Iuni a Europa le Abilify (Aripiprazole) i le togafitiga o le lisi o talosaga.Schizophrenia e aafia ai le 1% o le faitau aofaʻi o le lalolagi, ma sili atu i talavou matutua.O le schizophrenia e a'afia ai le mafaufau, pulea fa'alagona ma le malosi e fai filifiliga a le tagata ma'i.O tagata mama'i e maua i le Schizophrenia o le ai ai fa'ailoga e pei o le mafaufau ma le fa'a'ole'ole, o tagata mama'i e iai fa'ailoga le lelei o le fa'ate'a fa'aagafesootai, leai ni suiga fa'alagona.I le 2002 na faʻamaonia ai e le FDA le Abilify mo togafitiga o le schizophrenia, lea e lima faʻamalosi malosi: 5 mg, 10 mg, 15 mg, 20 mg ma le 30 mg, talu mai lona faʻatagaina.